In type II diabetes (T2DM), there is a deficit in b-cells, increased b-cell apoptosis and formation of intracellular membranepermeant oligomers of islet amyloid polypeptide (IAPP). Human-IAPP (h-IAPP) is an amyloidogenic protein co-expressed with insulin by b-cells. IAPP expression is increased with obesity, the major risk factor for T2DM. In this study we report that increased expression of human-IAPP led to impaired autophagy, due at least in part to the disruption of lysosome-dependant degradation. This action of IAPP to alter lysosomal clearance in vivo depends on its propensity to form toxic oligomers and is independent of the confounding effect of hyperglycemia. We report that the scaffold protein p62 that delivers polyubiquitinated proteins to autophagy may have a protective role against human-IAPP-induced apoptosis, apparently by sequestrating protein targets for degradation. Finally, we found that inhibition of lysosomal degradation increases vulnerability of b-cells to h-IAPPinduced toxicity and, conversely, stimulation of autophagy protects b-cells from h-IAPP-induced apoptosis. Collectively, these data imply an important role for the p62/autophagy/lysosomal degradation system in protection against toxic oligomer-induced apoptosis. Cell Death and Differentiation (2011) 18, 415-426; doi:10.1038/cdd.2010.111; published online 3 September 2010In type II diabetes (T2DM), hyperglycemia is because of inadequate insulin secretion in response to relative insulin resistance. The islet in T2DM is characterized by a deficit in b-cells, 1,2 increased b-cell apoptosis attributable to endoplasmic reticulum (ER) stress 3,4 and intracellular b-cell toxic aggregates of the amyloidogenic protein islet amyloid polypeptide (IAPP), 5 the expression of which increases with insulin resistance. 6 IAPP is co-expressed and co-secreted with insulin by b-cells 7 with its best-characterized physiological role being to inhibit insulin secretion through a direct paracrine effect on b-cells. 8 IAPP has the propensity to form amyloid fibrils in species at risk of T2DM (humans, non-human primates and cats). 9 In contrast to human-IAPP (h-IAPP), the rodent form of IAPP (r-IAPP) is non-amyloidogenic. Transgenic expression of h-IAPP in b-cells of rodents at rates present in insulin resistance leads to the development of diabetes because of ER stress-induced b-cell apoptosis with formation of membrane-damaging intracellular IAPP oligomers comparable to those present in humans with T2DM. 3,5,[10][11][12] Conserved mechanisms protect long-lived cells with a high protein synthetic burden (such as b-cells) from accumulation of intracellular protein aggregates and the adverse consequences termed proteotoxicity. 9 A quality control system in the ER recognizes misfolded proteins and targets them for degradation by the ubiquitin/proteasome system. 13 A second pathway of protein degradation, autophagy, also implies a role for ubiquitin in removal of misfolded proteins. 14 Macroautophagy (hereafter referred to as autophagy) permits selective autodi...